Vor Biopharma Inc.VORNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+63.1%
5Y CAGR+53.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+63.1%/yr
vs +133.1%/yr prior
5Y CAGR
+53.2%/yr
Recent acceleration
Acceleration
-70.1pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
8.4x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $366.13M | +202.1% |
| 2024 | $121.19M | -1.1% |
| 2023 | $122.54M | +45.1% |
| 2022 | $84.46M | +22.4% |
| 2021 | $69.02M | +59.2% |
| 2020 | $43.37M | +320.0% |
| 2019 | $10.33M | +261.0% |
| 2018 | $2.86M | - |